
1200 Pharma accelerates drug discovery and approval using innovative medicinal chemistry tech and biomarker assays.
1200 Pharma is a medicinal chemistry technology company focused on accelerating drug discovery and clinical approval timelines. Leveraging breakthrough technology from Caltech and proprietary biomarker-driven assays from UCLA, the company aims to deliver effective medicines to patients more quickly. Their market focus includes pre-clinical drug discovery and translational oncology, utilizing cutting-edge computational design and data-driven biological research.
Founded by a team of esteemed researchers from Caltech and UCLA, 1200 Pharma has made significant strides in the pharmaceutical industry. Their strategic partnerships and innovative approaches have positioned them as a key player in accelerating the development of new drugs. The company's impact is underscored by its commitment to getting better drugs to patients faster, enhancing both the efficiency and effectiveness of the drug discovery process.
Mint12 Pharma

Design Pharmaceuticals

PathDrugomics

Photonic Pharma
photonicpharma.com

Confluence Discovery Technologies

Camino Pharma
caminopharma.com

Pinpoint Pharma
pinpointpharma.co

Alcinous Pharmaceuticals
Kalypsys
kalypsys.com

PleoPharma
pleopharma.com

Discovery Innovations

Superluminal Medicines
superluminalrx.com

PharmaDirections

Enspire Bio

Bionaut Pharmaceuticals
Companies similar to 1200 Pharma include Mint12 Pharma, Design Pharmaceuticals, PathDrugomics and Photonic Pharma.
1200 Pharma was founded in 2017.
1200 Pharma's headquarters is located in Pasadena, CA, US.
1200 Pharma's most recent funding round was for $5.5M (USD) in November 2019.
As of Nov 26, 2019, 1200 Pharma has raised a total of $11.7M (USD).
1200 Pharma has 31 employees as of Feb 5, 2024.